Regulators Build an AI Arsenal: Unpacking the EMA 2025 Observatory Report

The European Medicines Agency has released its 2025 AI Observatory report, revealing how regulators are deploying 61 internal AI use cases to evaluate pharmaceutical submissions. Maya and Sam dive deep into the specific tools the EMA is building, the AI applications applicants are bringing to early meetings, and what this means for the future of drug development.

Key points

• The EMA is deploying tools like SCHEMA and REGULUS to independently verify safety data and process regulatory documents.
• The EU AI Act entered practical application in 2025, pushing AI from theoretical adoption to heavily governed practical use.
• Applicants are exploring radical AI use cases, from digital twins for manufacturing to predicting shelf-life without long-term stability data.
• A massive wave of EU-funded research is currently exploring AI applications in areas ranging from colorectal cancer stratification to autologous iPSC manufacturing.
• Significant regulatory gaps remain, specifically concerning model validation, explainability, and audit frameworks for regulatory-grade AI.

Source: 2025 AI Observatory report - European Medicines Agency, 2026

This spot is available. Reach clinicians, health-system leaders and medtech and pharma teams following AI in medicine. Sponsor the show

This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source.

Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/regulators-build-an-ai-arsenal-unpacking-the-ema-2025-observatory-repo-82a365